Insulet (PODD) Tops Q3 EPS by 4c; Boosts FY16 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
Insulet (PODD) Sales Momentum Appears Sustainable - Leerink; PT to $50
November 4, 2016 7:35 AM EDTLeerink Partners analyst Danielle Antalffy reiterated an Outperform rating but trimmed her price target on Insulet Corporation (NASDAQ: PODD) to $50.00 (from $55.00) following strong results, saying momentum appears sustainable, with profitably close.
Antalffy commented, "Another strong quarter of outperformance supports our recent view that PODD is shaping up to be if it isnt already one... More
BTIG Upgrades Insulet Corporation (PODD) to Buy
November 4, 2016 7:20 AM EDTBTIG upgraded Insulet Corporation (NASDAQ: PODD) from Neutral to Buy with a price target of $42.
Analyst Sean Lavin said, "Shares are likely to open today at around $35 and while we do not love chasing, we do see another 20% or so of... More



